Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption-Reference-Cited by-同舟云学术

Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption

Published:2017-08-25 Issue:10 Volume:32 Page:2062-2073
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Johnson Kristen¹,Levine Kymberly¹,Sergi Joseph¹,Chamoun Jean¹,Roach Rachel¹,Vekich Jacqueline¹,Favis Mike¹,Horn Mark¹,Cao Xianjun¹,Miller Brian¹,Snyder William¹,Aivazian Dikran¹,Reagan William²,Berryman Edwin³,Colangelo Jennifer²,Markiewicz Victoria²,Bagi Cedo M³,Brown Thomas P²,Coyle Anthony¹,Mohammadi Moosa⁴,Magram Jeanne¹

Affiliation:

1. Center for Therapeutic Innovation; Pfizer; New York NY USA

2. Drug Safety Research and Development; Pfizer; Groton CT USA

3. Comparative Medicine; Pfizer; Groton CT USA

4. Department of Biochemistry and Molecular Pharmacology; New York University School of Medicine; New York NY USA

Funder

Carol Fritz and other Biomarker team members for serum and urine chemistry analyses

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link